Bloomberg Businessweek Weekend - April 28th, 2023
Bloomberg Businessweek
00:00
The Battle for Obesity Drugs
We surveyed all 50 state Medicaid programs. Three quarters of the states have very little coverage for obesity drugs. Eight different states told us they're considering it. The big studies, the most important studies that are coming is that both Eli Lilly and Novo Nordisk are the two makers.
Play episode from 01:15:07
Transcript
